Singapore markets closed
Straits Times Index
3,300.04 -3.15 (-0.10%) S&P 500
5,191.23 +10.49 (+0.20%) Dow
38,961.02 +108.75 (+0.28%) Nasdaq
16,352.34 +3.09 (+0.02%) Bitcoin USD
63,512.43 -225.97 (-0.35%) CMC Crypto 200
1,312.73 -52.40 (-3.84%)
Incyte Corporation (INCY)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 10:49AM EDT. Market open.
| Previous close | 54.08 |
| Open | 54.50 |
| Bid | 54.32 x 400 |
| Ask | 54.45 x 400 |
| Day's range | 54.32 - 54.92 |
| 52-week range | 50.27 - 67.36 |
| Volume | |
| Avg. volume | 1,900,337 |
| Market cap | 12.211B |
| Beta (5Y monthly) | 0.67 |
| PE ratio (TTM) | 16.48 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Incyte to Present at Upcoming Investor Conference
WILMINGTON, Del., May 02, 2024--Incyte (Nasdaq:INCY) announced today that it will present at the Bank of America Securities 2024 Health Care Conference on Wednesday, May 15, 2024 at 8:00 a.m. (PDT) in Las Vegas.
- Business Wire
Incyte Reports 2024 First Quarter Financial Results and Provides Updates on Key Clinical Programs
WILMINGTON, Del., April 30, 2024--Incyte Reports 2024 First Quarter Financial Results and Provides Updates on Key Clinical Programs
- Business Wire
Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists
WILMINGTON, Del. & SAN DIEGO, April 23, 2024--Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists
© 2024 Yahoo. All rights reserved.